Articles related to BUSINESS & POLICY

Join Dr. Ira Klein at the CPC and CBEx Annual Congress as he demystifies AI in cancer care, providing practical insights and discussing future opportunities. Learn how AI can be harnessed to improve patient care, manage data, and streamline service requests.

Recent financial pressures have led to the sudden closure of key ketamine clinics across the US, disrupting ongoing treatment for numerous patients. The experience underscores the importance of strategic financial and operational planning, while hinting at future consolidation opportunities within the industry.

SIVAD Diagnostic Medical Group’s novel drug testing strips, HarmGuard FX, are making strides in harm reduction, beginning in Delaware. These strips, a part of the wider Harm Stopper Program, signal a potential turning point in the battle against the national opioid crisis.

The potential removal of the DIEP flap’s unique medical billing code by CMS could pose significant barriers to this beneficial breast reconstruction option, prompting calls for its preservation to ensure continued access and patient choice. Dive in to explore the implications of this pivotal issue for breast cancer patients and the health care system.

ASCO and SGO have taken a proactive stance on the chemotherapy drug shortage, issuing comprehensive guidelines to aid physicians in treating six specific cancers, ensuring that the crisis does not impede effective patient care.

Examine how programs like Hospital at Home are changing the face of healthcare, providing acute treatment outside of hospitals, enhancing patient outcomes, and ushering in a new era of patient-centered care.